Year All20252024202320222021202020192018201720162015201420122011 Feb 25, 2016 Ardelyx to Report Fourth Quarter and Full Year 2015 Financial Results on March 4th, 2016 Feb 2, 2016 Ardelyx to Present at the 2016 Leerink Partners Global Healthcare Conference Jan 13, 2016 Ardelyx Announces Closing of Public Offering Including Exercise of Underwriters' Right to Purchase Additional Shares Jan 7, 2016 Ardelyx Announces Pricing of Public Offering of Common Stock Jan 6, 2016 Ardelyx Announces Proposed Public Offering of Common Stock Jan 5, 2016 Ardelyx Reports Positive Clinical Results of RDX022 for the Treatment of Hyperkalemia Jan 4, 2016 Ardelyx Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Executive Vice President and Chief Medical Officer Nov 12, 2015 Ardelyx Reports Third Quarter 2015 Financial Results Oct 29, 2015 Ardelyx to Report Third Quarter 2015 Financial Results on November 12, 2015 Oct 28, 2015 Ardelyx Announces Upcoming Presentations for Tenapanor at the American Society of Nephrology's Kidney Week Meeting 2015